273 reports of this reaction
3.6% of all HYDROXYZINE PAMOATE reports
#1 most reported adverse reaction
COMPLETED SUICIDE is the #1 most commonly reported adverse reaction for HYDROXYZINE PAMOATE, manufactured by Amneal Pharmaceuticals of New York LLC. There are 273 FDA adverse event reports linking HYDROXYZINE PAMOATE to COMPLETED SUICIDE. This represents approximately 3.6% of all 7,494 adverse event reports for this drug.
Patients taking HYDROXYZINE PAMOATE who experience completed suicide should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
COMPLETED SUICIDE is moderately reported among HYDROXYZINE PAMOATE users, representing a notable but not dominant share of adverse events.
In addition to completed suicide, the following adverse reactions have been reported for HYDROXYZINE PAMOATE:
The following drugs have also been linked to completed suicide in FDA adverse event reports:
COMPLETED SUICIDE has been reported as an adverse event in 273 FDA reports for HYDROXYZINE PAMOATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
COMPLETED SUICIDE accounts for approximately 3.6% of all adverse event reports for HYDROXYZINE PAMOATE, making it one of the most commonly reported side effect.
If you experience completed suicide while taking HYDROXYZINE PAMOATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.